Screener
MapLight Therapeutics, Inc. MPLT Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by MapLight Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: MapLight Therapeutics, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:25 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224129
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $55,707 | $46,729 |
| Short-term investments | 254,406 | 258,374 |
| Prepaid expenses and other current assets | 17,115 | 19,567 |
| Total current assets | 327,228 | 324,670 |
| Property and equipment, net | 968 | 1,095 |
| Long-term investments | 85,090 | 147,993 |
| Restricted cash | 207 | 207 |
| Right-of-use asset | 5,259 | 5,488 |
Item 1. Financial Statements.
FAQ
- What is MapLight Therapeutics, Inc.'s total current assets?
- MapLight Therapeutics, Inc. (MPLT) reported total current assets of $327.23M in Q1 2026.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about MapLight Therapeutics, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude